B1-antagonists

US8865702B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Iris Kauffmann-Hefner · Biberach an der Riß, DE
• Angelo Ceci · Mittelbiberach, DE
• Henri Doods · Warthausen, DE
• Norbert Hauel · Schemmerhofen, DE
• Ingo Konetzki · Warthausen, DE
• Annette Schuler-Metz · Ulm, DE
• Rainer Walter · Biberach, DE

Key dates

• Filing date: Jul 23, 2008
• Grant date: Oct 21, 2014
• Expiry date: Feb 7, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Disclosed are compounds of the formula Iwherein A, Y, R1, R2, R3, R4 and R5 are defined, suitable for treating diseases and symptoms of diseases caused at least to some extent by stimulation of bradykinin-B1 receptors, the preparation thereof and the use thereof.